Dexamethasone and Nutraceutical Therapy Can Reduce the Myalgia Due to COVID-19 – a Systemic Review of the Active Substances that Can Reduce the Expression of Interlukin-6

BACKGROUND: Myalgia reflects generalized inflammation and cytokine response and can be the onset symptom of 36% of patients with COVID-19. Interleukin-6 (IL-6) and tumor necrosis factor-α (TNF- α) levels in plasma and upper respiratory secretions directly correlate with the magnitude of viral replic...

Descripción completa

Detalles Bibliográficos
Autores principales: Ripani, Umberto, Bisaccia, Michele, Meccariello, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Medical Sciences of Bosnia and Herzegovina 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976893/
https://www.ncbi.nlm.nih.gov/pubmed/35422571
http://dx.doi.org/10.5455/medarh.2022.76.66-71

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976893/
https://www.ncbi.nlm.nih.gov/pubmed/35422571
http://dx.doi.org/10.5455/medarh.2022.76.66-71

Ejemplares similares